Stienlauf Shmuel, Yahalom Vered, Schwartz Eli, Shinar Eilat, Segal Gad, Sidi Yechezkel
Sheba Medical Center, Tel Hashomer, Israel.
Emerg Infect Dis. 2009 Jul;15(7):1116-8. doi: 10.3201/eid1507.080796.
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.